Results 111 to 120 of about 1,428,643 (254)
Internal Involvement in Localized Scleroderma
We studied 76 consecutive patients with localized scleroderma (morphea with or without linear scleroderma) and analyzed the frequency, prognosis, and predictors of internal involvement in a subset of 53 patients systematically investigated for the presence of such involvement.
Anne Cosnes+3 more
openaire +3 more sources
Quality of Life and Optimism in Patients with Morphea [PDF]
Despite extensive knowledge about quality of life of people suffering from dermatological diseases, data on patients with morphea are scarce. The aim of our study was to compare the quality of life of healthy controls and morphea patients, as well as to ...
Aleksandra Dańczak-Pazdrowska+5 more
core +1 more source
Scleroderma-Like Lupus Panniculitis: A Case Report and Literature Review
Prinpat Pinyowiwat, Suthinee Rutnin, Kumutnart Chanprapaph Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Kumutnart Chanprapaph, Division of Dermatology ...
Pinyowiwat P, Rutnin S, Chanprapaph K
doaj
ABSTRACT Skin fibrosis in scleroderma is a chronic and debilitating condition that affects the quality of life of patients. In this study, we fabricated a niosomal hydrogel containing bromelain to reduce skin collagen and improve skin softness in scleroderma patients.
Hanieh Ardeshiri+5 more
wiley +1 more source
Jaishree Sharad Skinfiniti Aesthetic Skin and Laser Clinic, Mumbai, Maharashtra, IndiaCorrespondence: Jaishree Sharad, Skinfiniti Aesthetic Skin and Laser Clinic, 601, Prabhat Chambers, Khar West, S.V.Road, Mumbai, Maharashtra, 400052, India, Tel ...
Sharad J
doaj
The second messenger cyclic AMP (cAMP) dedifferentiates pathologic lung and skin myofibroblasts derived from patients with scleroderma by inhibiting the MAPK p38α. Though cAMP has anti‐fibrotic effects in fibroblasts from both organs, the cellular capacity to generate cAMP in response to the canonical stimulus prostaglandin E2 (PGE2) is substantially ...
Jared D. Baas+4 more
wiley +1 more source
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy [PDF]
Background: Fibrosis may be considered the hallmark of systemic sclerosis (SSc), the end stage triggered by different pathological events. Transforming growth factor-β (TGF-β) and platelet-derived growth factor BB (PDGF-BB) are profibrotic molecules ...
Berardicurti O.+11 more
core +1 more source
Objective Little is known on the mechanisms necessary to maintain the physiologic adult human skin integrity. This study aims to quantitatively describe anatomic changes in systemic sclerosis (SSc)–skin compared with controls and investigate the underlying mechanisms.
Sara Chenguiti Fakhouri+18 more
wiley +1 more source
Narrowing Down Key Players in Autoimmunity via Single‐Cell Multiomics
This review explores how single‐cell sequencing and multiomics reveal cell states and communication networks involved in autoimmunity. We highlight insights into antigen specificity and autoreactive lymphocytes, uncovering mechanisms like molecular mimicry.
Altea Gjurgjaj, Cecilia Domínguez Conde
wiley +1 more source
Сучасні аспекти патогенетичної терапії хворих на склеродермію. Огляд літератури [PDF]
Дані літератури свідчать, що традиційні лікарські препарати у хворих на склеродермію ефективні далеко не завжди; багато з них спричиняють різні побічні реакції, що обумовлює пошук принципово нових терапевтичних технологій, у тому числі – з використанням ...
Горбунцов, В.В.+2 more
core